The Patent Finder

Prelude Therapeutics Incorporated

Also on record
Records under this name other than the patents Prelude Therapeutics Incorporated holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 16 patents it holds.

Showing 1 to 5 of 5 · Back to Prelude Therapeutics Incorporated

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 11,220,524Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)
Lapsed on the fee record
Ended Jan 11, 2026 · USPTO record
Lapsed on the fee recordEnded Jan 11, 2026USPTO record
US 11,214,574Selective Inhibitors of Protein Arginine Methyltransferase 5 (PRMT5)
Lapsed on the fee record
Ended Jan 4, 2026 · Medium confidence
Lapsed on the fee recordEnded Jan 4, 2026Medium confidence
US 11,208,416Selective inhibitors of protein arginine methytransterase 5 (PRMT5)
Lapsed on the fee record
Ended Dec 28, 2025 · USPTO record
Lapsed on the fee recordEnded Dec 28, 2025USPTO record
US 11,130,769Spiro-sulfonamide derivatives as inhibitors of myeloid cell leukemia-1 (MCL-1) protein
Lapsed on the fee record
Ended Sep 28, 2025 · USPTO record
Lapsed on the fee recordEnded Sep 28, 2025USPTO record
US 11,078,205Selective inhibitors of protein arginine methlytransferase 5 (PRMT5)
Lapsed on the fee record
Ended Aug 3, 2025 · USPTO record
Lapsed on the fee recordEnded Aug 3, 2025USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited